Question 1

What specific benefits do you think BQ-788 might offer for my melanoma?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments or check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other clinical trials available that might be a better fit for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma clinical trial (NCT02442466). Contact the study team or your healthcare provider for specific answers.

What this study is about